Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting

BACKGROUND: Oral corticosteroids (OCS) are commonly administered in patients with severe persistent allergic asthma. Despite their efficacy, they are associated with a wide variety of adverse events. The eXpeRience registry was set up to investigate real-world outcomes among patients receiving omali...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Braunstahl, Gert-Jan, Chlumský, Jan, Peachey, Guy, Chen, Chien-Wei
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2013
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3879326/
https://ncbi.nlm.nih.gov/pubmed/24305549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1710-1492-9-47
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky